< Grace L. Guo MBBS, Ph.D. EOHSI Directory | EOHSI


Grace L. Guo MBBS, Ph.D.

Associate Professor Rutgers University – Ernest Mario School of PharmacyEOHSI – Toxicology
Work EOHSI Room 322 170 Frelinghuysen Rd Piscataway NJ 08854 Work Phone: 848-445-8186 (office) Work Phone: 848-445-6102 (Lab) Work Fax: 732-445-4161
Photo of Grace L. Guo MBBS, Ph.D.

Biographical Info

Dr. Guo is an Associate Professor at the Department Pharmacology and Toxicology in the Ernest Mario School of Pharmacy of Rutgers University. She is an adjunct faculty of the Department of Pharmacology, Toxicology and Therapeutics in School of Medicine at the University of Kanas Medical Center.  Dr. Guo obtained her MBBS degree from the West China University of Medical Sciences in 1993 and a PhD degree from the University of Kansas Medical Center in 2001, as well as post-doctoral training at the NCI, NIH in 2004. From 2004-2012, Dr. Guo has served as a faculty at the University of Kansas Medical Center.

Research Areas

Liver is essential for life and liver functions are tightly regulated. Particularly, the impact of intestine on liver homeostasis, function and diseases is significant, but this impact has been less studied. Our group has been focusing on determining the effects of intestine-liver crosstalks on liver metabolism and pathogenesis and the underlying molecular mechanisms, especially following disruption of endogenous homeostasis and exposure to xenobiotic chemicals.

Scholarly Activities

  • 2012: Presidential Poster Award, AASLD meeting (2)
  • 2011: Presidential Poster Award, AASLD meeting
  • 2010: Presidential Poster Award, AASLD meeting
  • 2009: Presidential Poster Award, AASLD meeting
  • 2009: Post award winner for Annual Liver Center Symposium, University of Kansas Medical Center
  • 2007: First place in oral presentation in Annual Cancer Center Symposium, University of Kansas Medical Center
  • 2005: BIRCWH/NIH scholar

Recent Publications

  1. Huang, M, Kong, B, Zhang, M, Rizzolo, D, Armstrong, LE, Schumacher, JD, Chow, MD, Lee, YH, Joseph, LB, Stofan, M et al.. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency. Lab. Invest. 2020;100 (9):1158-1168. doi: 10.1038/s41374-020-0439-y. PubMed PMID:32404932
  2. Adams, S, Wiersielis, K, Yasrebi, A, Conde, K, Armstrong, L, Guo, GL, Roepke, TA. Sex- and age-dependent effects of maternal organophosphate flame-retardant exposure on neonatal hypothalamic and hepatic gene expression. Reprod. Toxicol. 2020;94 :65-74. doi: 10.1016/j.reprotox.2020.04.001. PubMed PMID:32360330 PubMed Central PMC7303001
  3. Ferrucci-Da Silva, C, Zhan, L, Shen, J, Kong, B, Campbell, MJ, Memon, N, Hegyi, T, Lu, L, Guo, GL. Effects of total parenteral nutrition on drug metabolism gene expression in mice. Acta Pharm Sin B. 2020;10 (1):153-158. doi: 10.1016/j.apsb.2019.10.012. PubMed PMID:31993312 PubMed Central PMC6976970
  4. Guo, GL, Chiang, JYL. Is CYP2C70 the key to new mouse models to understand bile acids in humans?. J. Lipid Res. 2020;61 (3):269-271. doi: 10.1194/jlr.C120000621. PubMed PMID:31964761 PubMed Central PMC7053840
  5. Green, AL, Eid, A, Zhan, L, Zarbl, H, Guo, GL, Richardson, JR. Epigenetic Regulation of the Ontogenic Expression of the Dopamine Transporter. Front Genet. 2019;10 :1099. doi: 10.3389/fgene.2019.01099. PubMed PMID:31749842 PubMed Central PMC6844290
  6. Nikonorova, IA, Zhu, Q, Signore, CC, Mirek, ET, Jonsson, WO, Kong, B, Guo, GL, Belden, WJ, Anthony, TG. Age modulates liver responses to asparaginase-induced amino acid stress in mice. J. Biol. Chem. 2019;294 (38):13864-13875. doi: 10.1074/jbc.RA119.009864. PubMed PMID:31413113 PubMed Central PMC6755797
  7. Schumacher, JD, Kong, B, Wu, J, Rizzolo, D, Armstrong, LE, Chow, MD, Goedken, M, Lee, YH, Guo, GL. Direct and Indirect Effects of Fibroblast Growth Factor (FGF) 15 and FGF19 on Liver Fibrosis Development. Hepatology. 2020;71 (2):670-685. doi: 10.1002/hep.30810. PubMed PMID:31206730 PubMed Central PMC6918008
  8. Schumacher, JD, Guo, GL. Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis. Handb Exp Pharmacol. 2019;256 :325-357. doi: 10.1007/164_2019_228. PubMed PMID:31201553 PubMed Central PMC7033713
  9. Armstrong, LE, Guo, GL. Understanding Environmental Contaminants' Direct Effects on Non-alcoholic Fatty Liver Disease Progression. Curr Environ Health Rep. 2019;6 (3):95-104. doi: 10.1007/s40572-019-00231-x. PubMed PMID:31090041 PubMed Central PMC6698395
  10. Byun, S, Jung, H, Chen, J, Kim, YC, Kim, DH, Kong, B, Guo, G, Kemper, B, Kemper, JK. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis. J. Biol. Chem. 2019;294 (22):8732-8744. doi: 10.1074/jbc.RA119.008360. PubMed PMID:30996006 PubMed Central PMC6552419
Search PubMed
Categories: Faculty, Toxicology, Member
Updated 3 months ago.
Skip to toolbar